MUC16 (CA125): tumor biomarker to cancer therapy, a work in progress
M Felder, A Kapur, J Gonzalez-Bosquet, S Horibata… - Molecular cancer, 2014 - Springer
Over three decades have passed since the first report on the expression of CA125 by
ovarian tumors. Since that time our understanding of ovarian cancer biology has changed …
ovarian tumors. Since that time our understanding of ovarian cancer biology has changed …
Methods for identification of CA125 from ovarian cancer ascites by high resolution mass spectrometry
CA125 is the most widely used tumour marker in ovarian cancer with unsatisfactory
sensitivity and specificity especially at early stage. It is quantified by antibody-based …
sensitivity and specificity especially at early stage. It is quantified by antibody-based …
Assessment of sialic acid diversity in cancer-and non-cancer related CA125 antigen using sialic acid-binding Ig-like lectins (Siglecs)
N Mitic, B Milutinovic, M Jankovic - Disease markers, 2012 - content.iospress.com
This study was aimed at obtaining insight into the diversity of sialic acids in cancer-and non-
cancer-related CA125 antigen, tumour marker of serous ovarian cancer. Starting from …
cancer-related CA125 antigen, tumour marker of serous ovarian cancer. Starting from …